HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration

Nature

Volumn 498, Issue 7454, 2013, Pages 376-379

  Cooper, Arik ^a   García, Mayra ^a   Petrovas, Constantinos ^a   Yamamoto, Takuya ^a   Koup, Richard A ^a   Nabel, Gary J ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE; HISTONE H2AX; PROTEIN P53; RALTEGRAVIR;

CYTOLOGY; DNA; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFECTIOUS DISEASE; INHIBITOR; PROTEIN; PUBLIC HEALTH;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; DNA DAMAGE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION; VIRUS INTERFERENCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84879422443     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12274     Document Type: Article

References (39)

1. Joint. United Nations Programme on HIV/AIDS. Global Report fact sheet: The global AIDS epidemic http://www.unaids.org/documents/20101123-FS-Global-em- en.pdf (2010).
2. Brenchley, J. M. et al. CD41 T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759 (2004).
3. Mattapallil, J. J. et al.Massive infection and loss ofmemory CD41 T cells inmultiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005).
4. Nishimura, Y. et al. Resting naive CD41 T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc. Natl Acad. Sci. USA 102, 8000-8005 (2005).
5. Aiken, C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71, 5871-5877 (1997).
6. Butler, S. L., Hansen, M. S. & Bushman, F. D. A quantitative assay for HIV DNA integration in vivo. Nature Med. 7, 631-634 (2001).
7. Leavitt, A. D., Robles, G., Alesandro, N. & Varmus, H. E. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 70, 721-728 (1996).
8. Li, L. et al. Role of the non-homologous DNAend joining pathway in the early steps of retroviral infection. EMBO J. 20, 3272-3281 (2001).
9. Chen, H., Boyle, T. J., Malim, M. H., Cullen, B. R. & Lyerly, H. K. Derivation of a biologically contained replication systemfor human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 89, 7678-7682 (1992).
10. Doitsh, G. et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143, 789-801 (2010).
11. Daniel, R., Katz, R. A. & Skalka, A. M. A role for DNA-PK in retroviralDNA integration. Science 284, 644-647 (1999).
12. Baekelandt, V. et al. DNA-dependent protein kinase is not required for efficient lentivirus integration. J. Virol. 74, 11278-11285 (2000).
13. Daniel, R. et al.Wortmannin potentiates integrase-mediated killing of lymphocytes and reduces the efficiency of stable transduction by retroviruses. Mol. Cell. Biol. 21, 1164-1172 (2001).
14. Ariumi, Y., Turelli, P., Masutani, M. & Trono, D. DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration. J. Virol. 79, 2973-2978 (2005).
15. Callén, E. et al. Essential role for DNA-PKcs in DNAdouble-strand break repair and apoptosis in ATM-deficient lymphocytes. Mol. Cell 34, 285-297 (2009).
16. Engelman, A., Mizuuchi, K.& Craigie, R. HIV-1 DNAintegration: mechanismof viral DNA cleavage and DNA strand transfer. Cell 67, 1211-1221 (1991).
17. Morozov, V. E., Falzon, M., Anderson, C. W. & Kuff, E. L. DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps. J. Biol. Chem. 269, 16684-16688 (1994).
18. Lau, A., Kanaar, R., Jackson, S. P. & O'Connor, M. J. Suppression of retroviral infection by the RAD52 DNA repair protein. EMBO J. 23, 3421-3429 (2004).
19. Hill, R.& Lee, P. W. The DNA-dependent protein kinase (DNA-PK):More than just a case of making ends meet? Cell Cycle 9, 3460-3469 (2010).
20. Nilsson, A., Sirzen, F., Lewensohn, R., Wang, N. & Skog, S. Cell cycle-dependent regulation of the DNA-dependent protein kinase. Cell Prolif. 32, 239-248 (1999).
21. Chen, B. P. et al. Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J. Biol. Chem. 280, 14709-14715 (2005).
22. Nagasawa, M. et al. Nuclear translocation of the catalytic component of DNAdependent protein kinase upon growth stimulation in normal human T lymphocytes. Cell Struct. Funct. 22, 585-594 (1997).
23. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586 (1996).
24. Igarashi, T. et al. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD41 T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc.Natl Acad. Sci. USA 98, 658-663 (2001).
25. Shan, L. et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36, 491-501 (2012).
26. Ho, D. D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126 (1995).
27. Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122 (1995).
28. Mart́nez, E. et al. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. AIDS 26, 2315-2326 (2012).
29. Collman, R. et al. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66, 7517-7521 (1992).
30. Adachi, A. et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectiousmolecular clone. J. Virol. 59, 284-291 (1986).
31. Bolton, D. L. & Lenardo, M. J. Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD41 T cells. J. Virol. 81, 8878-8890 (2007).
32. Yamamoto, T. et al. Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state. PLoS Pathog. 5, e1000279 (2009).
33. O'Doherty, U., Swiggard, W. J.& Malim, M. H. Humanimmunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74, 10074-10080 (2000).
34. Willmore, E. et al. A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia. Blood 103, 4659-4665 (2004).
35. Leahy, J. J. et al. Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg. Med. Chem. Lett. 14, 6083-6087 (2004).
36. Komarov, P. G. et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733-1737 (1999).
37. Suzuki, Y. et al. Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells. Virus Genes 27, 177-188 (2003).
38. Li, Y. et al. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J. Virol. 66, 6587-6600 (1992).
39. O'Doherty, U., Swiggard, W. J., Jeyakumar, D., McGain, D. & Malim, M. H. A sensitive, quantitative assay for human immunodeficiency virus type 1 integration. J. Virol. 76, 10942-10950 (2002).